Clinical cardiac electrophysiology has evolved rapidly over the past 2 decades. Although the fast pace of technical and therapeutic advances has occasionally outpaced evidence supporting widespread effectiveness, the highlights of electrophysiology research in 2016 illustrate the emergence of robust evidence for implementation of several important therapies.
This is a preview of subscription content, log in via an institution to check access.
References
Bardy, G. H. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225–237 (2005).
Epstein, A. E. et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 127, e283–e352 (2013).
Kober, L. et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N. Engl. J. Med. 375, 1221–1230 (2016).
Curtis, L. H. et al. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure. Am. Heart J. 165, 979–986.e1 (2013).
Tang, A. S. et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363, 2385–2395 (2010).
Sapp, J. L. et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N. Engl. J. Med. 375, 111–121 (2016).
Gillinov, A. M. et al. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N. Engl. J. Med. 374, 1911–1921 (2016).
January, C. T. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130, e199–e267 (2014).
Packer, D. L. et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J. Am. Coll. Cardiol. 61, 1713–1723 (2013).
Kuck, K. H. et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 374, 2235–2245 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B.A.S. receives research funding support from Janssen, serves as a consultant to BMS/Pfizer, and receives educational support from Biotronik, Boston Scientific, Medtronic, and St. Jude Medical. J.P.P. receives funding for clinical research from ARCA Biopharma, Boston Scientific, Gilead, Janssen Pharmaceuticals, ResMed, Spectranetics, and St. Jude Medical, and serves as a consultant to Allergan, Amgen, GlaxoSmithKline, Johnson & Johnson, Medtronic, and Spectranetics.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Steinberg, B., Piccini, J. Arrhythmia treatment — evidence catching up with technology. Nat Rev Cardiol 14, 75–76 (2017). https://doi.org/10.1038/nrcardio.2016.219
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2016.219
- Springer Nature Limited